"A risk factor tells a person about his/her chance of acquiring a disease. However, it is not always necessary that the person will develop the illness, like in the case of breast cancer. So why is it important? Well, knowing one’s risk towards a disease helps to screen for it and detect it early in case it does occur. Breast cancer risk factors can be of the following types:
Inherent or unchangeable
Call +91-8010-994-994 and talk to Credi Medical Experts for FREE. Get assistance in choosing the right breast cancer doctor in India, compare treatment cost from various centers and timely medical updates."
Breast cancer risk assessment differs from breast cancer diagnosis. The goal of breast cancer risk assessment is to find high risk women before they develop cancer so there is a possibility of preventing the disease. Breast Cancer risk assessment does not take the place of routine screening and diagnosis of breast abnormalities. Go to www.NeoMatrix.com for more information.
NeoMatrix has up to date breast health information including breast cancer risk factors and information on the new HALO Breast Pap Test. Go to www.NeoMatrix.com for more information.
http://www.neomatrix.com - The HALO Test is a noninvasive way to check for early signs of breast cancer risk. Statistics show that 1 in 8 women in the US will develop breast cancer. This new test looks for abnormal cells that indicate a high risk for developing breast cancer. HALO can help to screen for first signs of breast cancer risk 8 years before cancer might be detected with a mammogram. It is especially useful for younger women 25 or older for whom breast cancer is often more aggressive. Learn more at http://www.neomatrix.com
The HALO Test is a new way to discover breast cancer risk. This screening test is for women 25 and older and takes only 5 minutes. HALO extracts fluid from a woman's nipple using warmth, massage and gentle suction. The fluid is then sent to a lab for analysis. The HALO Pap Test does not replace mammograms, but can help to assess a woman's risk for breast cancer years earlier than a mammogram. It works like a pap smear by detecting changes at the cellular level. This new breast cancer risk test is also called the Pap Test for the Breast. Learn more at www.neomatrix.com
8 out of 9 women with breast cancer have no direct family history of the disease. Now there is a new and better way of determining breast cancer risk. The HALO Pap Test for the Breast is an early screening process for younger women. When younger women get breast cancer, it is usually more aggressive.
The HALO Test collects fluid from the breast ducts, which is then sent to a lab where it is analyzed for abnormal cells.
The results can help to determine a womans risk before cancer develops and well before a lump surfaces, since women with abnormal cells are 4-5 times more likely to develop breast cancer.
The HALO Test allows doctors to customize a care plan for optimal management of breast health. HALO is recommended as a part of an annual Well Women Visit for women 25 and older. Read more at www.neomatrix.com
www.neomatrix.com - Early detection is key in fighting breast cancer. The new HALO exam uses a device that aspirates fluid from the nipple. The adjustable cups are fitted to a woman's breasts. The system applies warmth, suction and massage, bringing fluid to the surface of the nipple. A normal result is either no fluid aspirated or the fluid is without atypical cells. If cells are atypical, there is a 4 to 5 times increased chance of developing breast cancer. HALO is not designed to diagnose. It is a risk assessment tool. Halo can help women to assess their breast cancer risk level early. Learn more at www.neomatrix.com
www.neomatrix.com - Dr. Walker explains the new recommended screening rules for mammograms and four main strategies for early breast cancer detection.
One breast cancer risk screening strategy involves the HALO Pap Test for the Breast, that can help to identify high risk women 3 years before any signs show up on a mammogram.
To learn more about the HALO Test go to www.neomatrix.com
Reproductive endocrinologist & surgeon Dr. Adamson explains if women who have a baby later in life are at higher risk for breast cancer. For more pregnancy info go to http://www.EmpowHer.com. Share your fertility story & send this to a friend.
A new study published in the February 5, 2009, edition of the New England Journal of Medicine, found that women who take Estrogen-Progestin combination hormone therapy for more than five years suffer a doubling of their risk of getting breast cancer and the risk doubles again every additional twelve months they continue to take the drugs. Women are confused. Distributed by Tubemogul.
A study published in Environmental Health claims the use of certain household cleaning products increases the risk of breast cancer.
Learn how Essential Fatty Acids (EFAs) can reduce the risk of breast cancer. Dr. Meschino, explains the roles that EFAs & "bad fats" play in the development of breast cancer and dietary and lifestyle changes that all women should know. http://meschinohealth.com/LP/BreastCancerPreventionTips/
Click link above for FREE eBOOK download
Learn how studies show higher melatonin levels reduce the risk of breast cancer. Dr. Meschino, explains how melatonin works and how melatonin levels effect the risk of breast cancer development. http://meschinohealth.com/LP/BreastCancerPreventionTips/
Click link above for FREE eBOOK download
The HALO breast pap test is a new breast cancer risk assessment test developed by NeoMatrix. The HALO test can detect precancerous cells years earlier than a mammogram. This new screening test is non-invasive and is most effective for women between the ages of 25 and 50.
To learn more go to
www.neomatrix.com - The FDA-approved HALO Breast Pap Test is a simple, five-minute test that identifies warning signs of breast cancer risk long before cancer might develop and years before traditional mammograms and manual exams uncover an actual lump. The HALO test provides early warning signs of breast cancer risk, particularly among younger women who have no other known risk factors. This early breast cancer warning system gives women and their doctors precious extra time to implement a more vigilant, personalized breast health treatment plan.
http://www.neomatrix.com - HALO is a microscopic cellular test for breast cancer risk. This 5 minute test determines whether or not there are abnormal cells in the breast ducts. HALO is recommended for women age 25 and older as part of their annual exam. This new method of breast cancer risk monitoring adds an extra layer of safety to every woman's life. Learn more at http://www.neomatrix.com